Sonoma Pharmaceuticals, Inc. (SNOA)
2.84
+0.03
(+1.07%)
USD |
NASDAQ |
Feb 19, 16:00
Sonoma Pharmaceuticals Profit Margin (Quarterly) : -18.83% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -81.97% |
| Return on Assets | -24.23% |
| Return on Invested Capital | -73.76% |
| Gross Profit Margin (Quarterly) | 37.94% |
| Operating Margin (Quarterly) | -15.59% |
| Return on Net Operating Assets | -48.78% |